The price-to-earnings ratio for Elevance Health Inc (NYSE: ELV) is 14.01x, which is above its average ratio. Moreover, the 36-month beta value for ELV is 0.83. Analysts have varying opinions on the stock, with 14 analysts rating it as a “buy,” 4 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for ELV is 231.43M and currently, short sellers hold a 1.57% of that float. On January 15, 2025, ELV’s average trading volume was 2.01M shares.
ELV) stock’s latest price update
Elevance Health Inc (NYSE: ELV)’s stock price has gone decline by -2.22 in comparison to its previous close of 393.16, however, the company has experienced a 0.97% increase in its stock price over the last five trading days. businesswire.com reported 2025-01-09 that INDIANAPOLIS–(BUSINESS WIRE)–Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access Code – 3972058 (Domestic) 312-470-0178 – Access Code – 3972058 (Inte.
ELV’s Market Performance
Elevance Health Inc (ELV) has experienced a 0.97% rise in stock performance for the past week, with a 1.59% rise in the past month, and a -24.48% drop in the past quarter. The volatility ratio for the week is 2.61%, and the volatility levels for the past 30 days are at 2.34% for ELV. The simple moving average for the past 20 days is 2.50% for ELV’s stock, with a -21.31% simple moving average for the past 200 days.
Analysts’ Opinion of ELV
BofA Securities, on the other hand, stated in their research note that they expect to see ELV reach a price target of $530, previously predicting the price at $646. The rating they have provided for ELV stocks is “Neutral” according to the report published on July 18th, 2024.
Morgan Stanley gave a rating of “Overweight” to ELV, setting the target price at $643 in the report published on June 24th of the previous year.
ELV Trading at -2.09% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.23% of loss for the given period.
Volatility was left at 2.34%, however, over the last 30 days, the volatility rate increased by 2.61%, as shares surge +0.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.22% lower at present.
During the last 5 trading sessions, ELV rose by +1.00%, which changed the moving average for the period of 200-days by -25.84% in comparison to the 20-day moving average, which settled at $375.05. In addition, Elevance Health Inc saw 4.21% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Kendrick Charles Morgan JR, who sale 7,417 shares at the price of $432.14 back on Oct 18 ’24. After this action, Kendrick Charles Morgan JR now owns 8,423 shares of Elevance Health Inc, valued at $3,205,182 using the latest closing price.
Kendrick Charles Morgan JR, the Director of Elevance Health Inc, proposed sale 7,417 shares at $432.28 during a trade that took place back on Oct 18 ’24, which means that Kendrick Charles Morgan JR is holding shares at $3,206,221 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.28 for the gross margin
The net margin for Elevance Health Inc stands at 0.04. The total capital return value is set at 0.12. Equity return is now at value 15.62, with 5.65 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.62. The interest coverage ratio of the stock is 8.34.
Currently, EBITDA for the company is 10.49 billion with net debt to EBITDA at 1.78. When we switch over and look at the enterprise to sales, we see a ratio of 0.62. The receivables turnover for the company is 15.55for trailing twelve months and the total asset turnover is 1.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.50.
Conclusion
To wrap up, the performance of Elevance Health Inc (ELV) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
